EUROPE ORTHOBIOLOGICS MARKET FORECAST 2017-2025
KEY FINDINGS
The Europe orthobiologics market is expected to grow $3077 million by 2025. The market growth is expected at the CAGR of 6.89% in the forecast period. The base year considered for the market study is 2016. Development of technology in European countries is the primitive factor influencing the growth of the orthobilogics market in Europe region.
MARKET INSIGHTS
The Europe orthobiologics market is segmented on the basis of product, end-user, application, and geography. The Europe market of orthobiologics by product is further segmented into the Bone morphogenetic protein (BMP), demineralized bone matrix (DBM), synthetic bone graft substitutes, viscosupplementation, stem cell therapy and other products. The market of end-user is segmented into hospital and clinics. The application segment is further classified into trauma repair, reconstructive surgery, and spinal fusion. The Europe orthobiologics market of geography is further segmented into United Kingdom, Germany, France, Spain, Italy, and rest of Europe. Increasing geriatric population and increasing incidents of osteoarthritis and osteoporosis is developing the market of orthobiologics in Europe at a faster pace.
COMPETETIVE INSIGHTS
Major players for the Orthobiologics market are Integra Life sciences Holding Corporation, Zimmer Biomet Inc., Bioventus, Mölnlycke Health Care AB, Nuvasive Inc., DePuy Inc. (Acquired by Johnson and Johnson), Medtronic Inc., Exatech Inc., Stryker Corporation, Johnson& Johnson, Globus Medical Inc., Sanofi, and RTI Surgical.
The Europe orthobiologics market is expected to grow $3077 million by 2025. The market growth is expected at the CAGR of 6.89% in the forecast period. The base year considered for the market study is 2016. Development of technology in European countries is the primitive factor influencing the growth of the orthobilogics market in Europe region.
MARKET INSIGHTS
The Europe orthobiologics market is segmented on the basis of product, end-user, application, and geography. The Europe market of orthobiologics by product is further segmented into the Bone morphogenetic protein (BMP), demineralized bone matrix (DBM), synthetic bone graft substitutes, viscosupplementation, stem cell therapy and other products. The market of end-user is segmented into hospital and clinics. The application segment is further classified into trauma repair, reconstructive surgery, and spinal fusion. The Europe orthobiologics market of geography is further segmented into United Kingdom, Germany, France, Spain, Italy, and rest of Europe. Increasing geriatric population and increasing incidents of osteoarthritis and osteoporosis is developing the market of orthobiologics in Europe at a faster pace.
COMPETETIVE INSIGHTS
Major players for the Orthobiologics market are Integra Life sciences Holding Corporation, Zimmer Biomet Inc., Bioventus, Mölnlycke Health Care AB, Nuvasive Inc., DePuy Inc. (Acquired by Johnson and Johnson), Medtronic Inc., Exatech Inc., Stryker Corporation, Johnson& Johnson, Globus Medical Inc., Sanofi, and RTI Surgical.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. DEMAND FOR SPINAL FUSION SURGERIES
4.1.2. GROWTH IN STRATEGIC PARTNERSHIPS
4.1.3. INCREASE IN ORTHOBIOLOGICS MATERIAL
4.2. RESTRAINTS
4.2.1. STRINGENT GOVERNMENT POLICIES
4.2.2. POST-SURGERY COMPLICATIONS
4.3. OPPORTUNITIES
4.3.1. BONE REGENERATION TECHNOLOGY
4.3.2. LARGER SPEND ON HEALTHCARE
4.4. CHALLENGES
4.4.1. HIGH COST OF SPINAL FUSION SURGERY
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
4.4.3. POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
5. SEGMENTATION
5.1. BY PRODUCTS
5.1.1. DEMINERALIZED BONE MATRIX (DBM)
5.1.2. ALLOGRAFT
5.1.3. BONE MORPHOGENETIC PROTEIN (BMP)
5.1.4. VISCOSUPPLEMENTATION
5.1.5. SYNTHETIC BONE GRAFT SUBSTITUTES
5.1.6. STEM CELL THERAPY
5.1.7. OTHERS PRODUCT MARKET
5.2. BY APPLICATION
5.2.1. SPINAL FUSION
5.2.2. TRAUMA REPAIR
5.2.3. RECONSTRUCTIVE SURGERY
5.2.4. TENDON & LIGAMENT REPAIR MARKET
5.2.5. OTHER APPLICATION MARKET
5.3. BY END-USER
5.3.1. HOSPITALS MARKET
5.3.2. CLINICS MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. VALUE CHAIN ANALYSIS
6.5. VENDOR LANDSCAPE
7. EUROPE ANALYSIS
7.1. EUROPE ORTHOBIOLOGICS MARKET
7.1.1. UNITED KINGDOM ORTHOBIOLOGICS MARKET
7.1.2. FRANCE ORTHOBIOLOGICS MARKET
7.1.3. GERMANY ORTHOBIOLOGICS MARKET
7.1.4. SPAIN ORTHOBIOLOGICS MARKET
7.1.5. ITALY ORTHOBIOLOGICS MARKET
7.1.6. ROAPAC ORTHOBIOLOGICS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. MERGERS & ACQUISITIONS
9. COMPANY PROFILE
9.1. BIOVENTUS
9.1.1. OVERVIEW
9.1.2. PRODUCTS PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.2. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. EXATECH INC
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT
9.3.4. STRATEGIC ANALYSIS
9.4. GLOBUS MEDICAL INC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT
9.4.5. STRATEGIC ANALYSIS
9.5. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. JOHNSON& JOHNSON
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. SCOT ANALYSIS
9.7. MEDTRONIC INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.8. NUVASIVE INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. RTI SURGICAL
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.10. SANOFI
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.11. STRYKER CORPORATION
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. ZIMMER BIOMET INC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT ANALYSIS
9.12.5. STRATEGIC ANALYSIS
9.13. MÖLNLYCKE HEALTH CARE AB
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES
9.13.4. SCOT ANALYSIS
TABLE LIST
TABLE 1 OLDER POPULATION BY AGE GROUP: 1900 TO 2050
TABLE 2 FINANCING FOR ORTHOBIOLOGICS ADVANCEMENT
TABLE 3 POST-SURGERY COMPLICATIONS
TABLE 4 EUROPE ORTHOBIOLOGICS MARKET BY PRODUCTS 2017-2025 ($ MILLIONS)
TABLE 5 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 6 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 7 BONE MORPHOGENETIC PROTEIN (BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 8 VISCOSUPPLEMENTATION MARKET 2017-2025 ($ MILLIONS)
TABLE 9 SYNTHETIC BONE GRAFT MARKET 2017-2025 ($ MILLIONS)
TABLE 10 STEM CELL THERAPY MARKET 2017-2025 ($ MILLIONS)
TABLE 11 OTHER PRODUCTS MARKET 2017-2025 ($ MILLIONS)
TABLE 12 EUROPE ORTHOBIOLOGICS MARKET BY APPLICATION 2017-2025 ($ MILLIONS)
TABLE 13 SPINAL FUSION MARKET 2017-2025 ($ MILLIONS)
TABLE 14 TRAUMA REPAIR MARKET 2017-2025 ($ MILLIONS)
TABLE 15 RECONSTRUCTIVE SURGERY MARKET 2017-2025 ($ MILLIONS)
TABLE 16 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 17 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 18 EUROPE ORTHOBIOLOGICS MARKET BY END-USER, 2017-2025 ($ MILLION)
TABLE 19 HOSPITAL ORTHOBIOLOGICS MARKET, 2017-2025 ($ MILLIONS)
TABLE 20 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
TABLE 21 EUROPE ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
FIGURES LIST
FIGURE 1 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 2 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 3 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 4 BONE MORPHOGENIC PROTEIN (BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 5 VISCOSUPPLEMENTATION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 6 SYNTHETIC BONE GRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 7 STEM CELL THERAPY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 8 EUROPE OTHER PRODUCTS MARKET 2017-2025 ($ MILLION)
FIGURE 9 SPINAL FUSION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 10 TRAUMA REPAIR ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 11 RECONSTRUCTIVE SURGERY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 12 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 13 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 14 COST OF KNEE REPLACEMENT IN DEVELOPING COUNTRIES IN 2017
FIGURE 15 ORTHOBIOLOGICS HOSPITAL MARKET 2017-2025 ($ MILLIONS)
FIGURE 16 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 17 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE 18 UNITED KINGDOM ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 19 FRANCE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 20 AGE STRUCTURE OF GERMANY 2015
FIGURE 21 GERMANY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 22 AGING POPULATION IN SPAIN 2005 AND 2015 (%)
FIGURE 23 SPAIN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 24 ITALY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 25 ROE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. DEMAND FOR SPINAL FUSION SURGERIES
4.1.2. GROWTH IN STRATEGIC PARTNERSHIPS
4.1.3. INCREASE IN ORTHOBIOLOGICS MATERIAL
4.2. RESTRAINTS
4.2.1. STRINGENT GOVERNMENT POLICIES
4.2.2. POST-SURGERY COMPLICATIONS
4.3. OPPORTUNITIES
4.3.1. BONE REGENERATION TECHNOLOGY
4.3.2. LARGER SPEND ON HEALTHCARE
4.4. CHALLENGES
4.4.1. HIGH COST OF SPINAL FUSION SURGERY
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
4.4.3. POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
5. SEGMENTATION
5.1. BY PRODUCTS
5.1.1. DEMINERALIZED BONE MATRIX (DBM)
5.1.2. ALLOGRAFT
5.1.3. BONE MORPHOGENETIC PROTEIN (BMP)
5.1.4. VISCOSUPPLEMENTATION
5.1.5. SYNTHETIC BONE GRAFT SUBSTITUTES
5.1.6. STEM CELL THERAPY
5.1.7. OTHERS PRODUCT MARKET
5.2. BY APPLICATION
5.2.1. SPINAL FUSION
5.2.2. TRAUMA REPAIR
5.2.3. RECONSTRUCTIVE SURGERY
5.2.4. TENDON & LIGAMENT REPAIR MARKET
5.2.5. OTHER APPLICATION MARKET
5.3. BY END-USER
5.3.1. HOSPITALS MARKET
5.3.2. CLINICS MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. VALUE CHAIN ANALYSIS
6.5. VENDOR LANDSCAPE
7. EUROPE ANALYSIS
7.1. EUROPE ORTHOBIOLOGICS MARKET
7.1.1. UNITED KINGDOM ORTHOBIOLOGICS MARKET
7.1.2. FRANCE ORTHOBIOLOGICS MARKET
7.1.3. GERMANY ORTHOBIOLOGICS MARKET
7.1.4. SPAIN ORTHOBIOLOGICS MARKET
7.1.5. ITALY ORTHOBIOLOGICS MARKET
7.1.6. ROAPAC ORTHOBIOLOGICS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. MERGERS & ACQUISITIONS
9. COMPANY PROFILE
9.1. BIOVENTUS
9.1.1. OVERVIEW
9.1.2. PRODUCTS PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.2. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. EXATECH INC
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT
9.3.4. STRATEGIC ANALYSIS
9.4. GLOBUS MEDICAL INC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT
9.4.5. STRATEGIC ANALYSIS
9.5. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. JOHNSON& JOHNSON
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. SCOT ANALYSIS
9.7. MEDTRONIC INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.8. NUVASIVE INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. RTI SURGICAL
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.10. SANOFI
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.11. STRYKER CORPORATION
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. ZIMMER BIOMET INC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT ANALYSIS
9.12.5. STRATEGIC ANALYSIS
9.13. MÖLNLYCKE HEALTH CARE AB
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES
9.13.4. SCOT ANALYSIS
TABLE LIST
TABLE 1 OLDER POPULATION BY AGE GROUP: 1900 TO 2050
TABLE 2 FINANCING FOR ORTHOBIOLOGICS ADVANCEMENT
TABLE 3 POST-SURGERY COMPLICATIONS
TABLE 4 EUROPE ORTHOBIOLOGICS MARKET BY PRODUCTS 2017-2025 ($ MILLIONS)
TABLE 5 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 6 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 7 BONE MORPHOGENETIC PROTEIN (BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 8 VISCOSUPPLEMENTATION MARKET 2017-2025 ($ MILLIONS)
TABLE 9 SYNTHETIC BONE GRAFT MARKET 2017-2025 ($ MILLIONS)
TABLE 10 STEM CELL THERAPY MARKET 2017-2025 ($ MILLIONS)
TABLE 11 OTHER PRODUCTS MARKET 2017-2025 ($ MILLIONS)
TABLE 12 EUROPE ORTHOBIOLOGICS MARKET BY APPLICATION 2017-2025 ($ MILLIONS)
TABLE 13 SPINAL FUSION MARKET 2017-2025 ($ MILLIONS)
TABLE 14 TRAUMA REPAIR MARKET 2017-2025 ($ MILLIONS)
TABLE 15 RECONSTRUCTIVE SURGERY MARKET 2017-2025 ($ MILLIONS)
TABLE 16 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 17 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE 18 EUROPE ORTHOBIOLOGICS MARKET BY END-USER, 2017-2025 ($ MILLION)
TABLE 19 HOSPITAL ORTHOBIOLOGICS MARKET, 2017-2025 ($ MILLIONS)
TABLE 20 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
TABLE 21 EUROPE ORTHOBIOLOGICS MARKET, BY COUNTRY 2017-2025 ($ MILLION)
FIGURES LIST
FIGURE 1 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 2 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 3 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 4 BONE MORPHOGENIC PROTEIN (BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 5 VISCOSUPPLEMENTATION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 6 SYNTHETIC BONE GRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 7 STEM CELL THERAPY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 8 EUROPE OTHER PRODUCTS MARKET 2017-2025 ($ MILLION)
FIGURE 9 SPINAL FUSION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 10 TRAUMA REPAIR ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 11 RECONSTRUCTIVE SURGERY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 12 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 13 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 14 COST OF KNEE REPLACEMENT IN DEVELOPING COUNTRIES IN 2017
FIGURE 15 ORTHOBIOLOGICS HOSPITAL MARKET 2017-2025 ($ MILLIONS)
FIGURE 16 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
FIGURE 17 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE 18 UNITED KINGDOM ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 19 FRANCE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 20 AGE STRUCTURE OF GERMANY 2015
FIGURE 21 GERMANY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 22 AGING POPULATION IN SPAIN 2005 AND 2015 (%)
FIGURE 23 SPAIN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 24 ITALY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE 25 ROE ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
